RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer

RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer

Abstract Background While prostate cancer can often manifest as an indolent disease, the development of locally-advanced or metastatic disease can cause significant morbidity or mortality. Elucidation of molecular mechanisms contributing to disease progression is crucial for more accurate prognostic...

Full description

Bibliographic Details
Main Authors: Aruz Mesci, Fabrice Lucien, Xiaoyong Huang, Eric H. Wang, David Shin, Michelle Meringer, Christianne Hoey, Jessica Ray, Paul C. Boutros, Hon S. Leong, Stanley K. Liu
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Journal of Translational Medicine
Subjects:
RSPO3
Prostate cancer
Invasion
Biochemical relapse
Online Access:http://link.springer.com/article/10.1186/s12967-019-1878-3

Internet

http://link.springer.com/article/10.1186/s12967-019-1878-3

Similar Items